Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Mayor

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|February 14, 2021
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studiesCarlota Dobaño, Rebeca Santano, Alfons Jiménez, et al.
Gates Open Research|June 8, 2019
Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria eliminationBryan Greenhouse, Jennifer Daily, Caterina Guinovart, et al.
Plos Medicine|September 24, 2014
Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trialRaquel González, Meghna Desai, Eusebio Macete, et al.
The Lancet. Global Health|October 20, 2023
Prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluationAntía Figueroa-Romero, Daniel Bissombolo, Martin Meremikwu, et al.
Malaria Journal|December 26, 2024
Molecular surveillance of Plasmodium falciparum histidine-rich protein 2/3 gene deletions in Mozambique, 2023Clemente da Silva, Dário Tembisse, Pau Cisteró, et al.
Malaria Journal|July 14, 2025
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022Abel Nhama, Arlindo Chidimatembue, Lídia Nhamussua, et al.
Immunobiology|January 25, 2011
IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamineDiana Quelhas, Alfons Jiménez, Llorenç Quintó, et al.
Diagnostic Microbiology and Infectious Disease|October 29, 2015
Infectious cause of death determination using minimally invasive autopsies in developing countriesMiguel J Martínez, Sergio Massora, Inácio Mandomando, et al.
Plos Medicine|August 16, 2020
A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after studyBeatriz Galatas, Francisco Saúte, Helena Martí-Soler, et al.
Malaria Journal|October 14, 2018
Prevalence of Plasmodium falciparum infection among pregnant women at first antenatal visit in post-Ebola Monrovia, LiberiaGuillermo Martínez-Pérez, Dawoh Peter Lansana, Senga Omeonga, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Translational Research : the Journal of Laboratory and Clinical Medicine|February 14, 2021
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studiesCarlota Dobaño, Rebeca Santano, Alfons Jiménez, et al.
Gates Open Research|June 8, 2019
Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria eliminationBryan Greenhouse, Jennifer Daily, Caterina Guinovart, et al.
Plos Medicine|September 24, 2014
Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trialRaquel González, Meghna Desai, Eusebio Macete, et al.
The Lancet. Global Health|October 20, 2023
Prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluationAntía Figueroa-Romero, Daniel Bissombolo, Martin Meremikwu, et al.
Malaria Journal|December 26, 2024
Molecular surveillance of Plasmodium falciparum histidine-rich protein 2/3 gene deletions in Mozambique, 2023Clemente da Silva, Dário Tembisse, Pau Cisteró, et al.
Malaria Journal|July 14, 2025
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022Abel Nhama, Arlindo Chidimatembue, Lídia Nhamussua, et al.
Immunobiology|January 25, 2011
IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamineDiana Quelhas, Alfons Jiménez, Llorenç Quintó, et al.
Diagnostic Microbiology and Infectious Disease|October 29, 2015
Infectious cause of death determination using minimally invasive autopsies in developing countriesMiguel J Martínez, Sergio Massora, Inácio Mandomando, et al.
Plos Medicine|August 16, 2020
A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after studyBeatriz Galatas, Francisco Saúte, Helena Martí-Soler, et al.
Malaria Journal|October 14, 2018
Prevalence of Plasmodium falciparum infection among pregnant women at first antenatal visit in post-Ebola Monrovia, LiberiaGuillermo Martínez-Pérez, Dawoh Peter Lansana, Senga Omeonga, et al.
Pageof 17